✦ LIBER ✦

The 5-HT4 receptor antagonist ML10375 inhibits the constitutive activity of human 5-HT4(c) receptor

✍ Scribed by Olivier Blondel; Monique Gastineau; Michel Langlois; Rodolphe Fischmeister

Book ID: 110003926
Publisher: Nature Publishing Group
Year: 1998
Tongue: English
Weight: 227 KB
Volume: 125
Category: Article
ISSN: 0007-1188
DOI: 10.1038/sj.bjp.0702163

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Blockade of human atrial 5-HT4receptors

Blockade of human atrial 5-HT4receptors by SB 207710, a selective and high affinity 5-HT4receptor antagonist

✍ Alberto J. Kaumann, Laramie M. Gaster, Frank D. King, Anthony M. Brown 📂 Article 📅 1994 🏛 Springer-Verlag 🌐 English ⚖ 290 KB

Inhibitory Activity of Antibodies Agains

Inhibitory Activity of Antibodies Against the Human Atrial 5-HT4Receptor

✍ Laurent Sallé; Pierre Eftekhari; Michel Aupart; Pierre Cosnay; Johan Hoebeke; Jo 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 190 KB

Constitutive dimerization of human serot

Constitutive dimerization of human serotonin 5-HT4 receptors in living cells

✍ Magali Berthouze; Mohammed Ayoub; Olivier Russo; Lucie Rivail; Sames Sicsic; Rod 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 323 KB

DAU 6285: A novel antagonist at the puta

DAU 6285: A novel antagonist at the putative 5-HT4 receptor

✍ Antonio Schiavone; Ettore Giraldo; Luciano Giudici; Marco Turconi; Angelo Sagrad 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 576 KB

5-HT Inhibits Spontaneous Contractility

5-HT Inhibits Spontaneous Contractility of Isolated Sheep Mesenteric Lymphatics via Activation of 5-HT4 Receptors

✍ N.G McHale; K.D Thornbury; M.A Hollywood 📂 Article 📅 2000 🏛 Elsevier Science 🌐 English ⚖ 132 KB

Comparative 5-HT4 receptor antagonist ac

Comparative 5-HT4 receptor antagonist activity of LY353433 and its active hydroxylated metabolites

✍ Marlene L. Cohen; William Bloomquist; David Calligaro; Steven Swanson 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 148 KB

LY353433 is a selective, potent, and orally active 5-HT 4 receptor antagonist with a long duration of pharmacological activity following its oral administration to rats. After oral administration of LY353433 (100 mg/kg) to rats, peak plasma concentration of the parent material was approximately 25 n